SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Epithelial cell states distinguish between uterine cancers
Fri December 3rd - Two epithelial cell states have been identified that can help to distinguish between types of uterine cancer, British researchers announced last night. More
COVID-19 boosters increase immunity
Fri December 3rd - Six different types of COVID-19 boosters are safe and increase immunity following vaccination with either the AstraZeneca or Pfizer-BioNTech jabs, British researchers report today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

DNA testing key to future health care - CMO

Tuesday July 4th, 2017

The NHS needs to undertake more DNA testing to speed up diagnosis of rare diseases and improve cancer treatment, the Chief Medical Officer says today.

In her annual report, Dame Sally Davies concentrates on the "potential" of genomics to improve health care.

She says that a centralised laboratory system of genetic testing could reduce costs - and calls for all clinicians to be trained in genetics.

There should also be a national genomics board, she says.

The report says that patients diagnosed with rare diseases have, on average, consulted five different doctors and waited four years for their condition to be correctly identified.

She said: “This technology has the potential to change medicine forever but we need all NHS staff, patients and the public to recognise and embrace its huge potential.

"Genomic medicine has huge implications for the understanding and treatment of rare disease, cancer and infections - ending the diagnostic odyssey and tailoring the treatment for more patients than ever before.

“I want all appropriate patients to get the opportunity. My dream is in the end that every patient gets their genome done if they’ve got cancer.”

The report was welcomed by the Wellcome Trust, which has pioneered genetic research in the UK.

Its head of genetics Dr Michael Dunn said: “It builds on the 100,000 genomes project and the Wellcome Sanger Institute’s DDD study, which have transformed the way genomic medicine operates. Both have shown that these cutting-edge technologies can be used to diagnose and treat cancer and rare diseases, paving the way for their widespread deployment.

“For many diseases, such as diabetes and cancer, there are still significant gaps in our knowledge that can only be addressed through ongoing fundamental discovery science.

"It’s important that the clinical delivery of genomic medicine continues to adapt and evolve as new research delivers a greater understanding of the genetic basis of disease.”

Tags: Cancer | General Health | Genetics | NHS | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES